Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
“…missing from red cells of individuals from equatorial and southern Africa (Chaudhuri et al., 1995; Peiper et al., 1995), the result of fixation of a variant allele bearing a single nucleotide mutation named 2 46C in an erythroid-specific GATA-1 site in the Duffy promoter (Tournamille et al., 1995).”
The evolutionary significance of cis-regulatory mutations
Wray, G. A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2063 · Cited by 1,521
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
The Evolution of Transcriptional Regulation in Eukaryotes
Wray, G. A. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg140 · Cited by 1,222
“…from cases in which the resulting transcription profile has been examined (e.g., Ross, Fong, and Cavener 1994; Odgers, Healy, and Oakeshott 1995; Tournamille et al. 1995; Belting, Shashikant, and Ruddle 1998; Indovina et al. 1998; Ludwig, Patel, and Kreitman 1998; Wang et al. 1999; Romano and…”
BackgroundHow Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria
Kwiatkowski, D. P. (2005) · The American Journal of Human Genetics · doi:10.1086/432519 · Cited by 1,104
“1999); variation in the chemokine receptor FY, which causes the Duffy-negative blood group (Miller et al. 1976; Chitnis and Miller 1994; Tournamille et al. 1995; Hamblin and Di Rienzo 2000); and polymorphisms of the redcell enzyme gene G6PD, which causes glucose-6-phosphate dehydrogenase deficiency (Bienzle et al.”
BackgroundInfluentialEvolution at Two Levels: On Genes and Form
Carroll, S. B. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030245 · Cited by 882
“This loss is due to a regulatory mutation that affects an erythroid cisregulatory sequence but has no effect on receptor expression elsewhere in the body [74].”
BackgroundBachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
“The third major ACKR1 polymorphism results from a T to C substitution at nucleotide-67 within the promoter region of the FYB allele at the binding site of the erythroid transcription factor GATA-1 (Tournamille et al., 1995).”
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Albalat, R., & Cañestro, C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.39 · Cited by 775
Estimating African American Admixture Proportions by Use of Population-Specific Alleles
Parra, E. J., Marcini, A., Akey, J., Martinson, J., Batzer, M. A., Cooper, R., Forrester, T., Allison, D. B., Deka, R., Ferrell, R. E., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302148 · Cited by 771
From evolutionary genetics to human immunology: how selection shapes host defence genes
Barreiro, L. B., & Quintana-Murci, L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2698 · Cited by 558
Natural selection and infectious disease in human populations
Karlsson, E. K., Kwiatkowski, D. P., & Sabeti, P. C. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3734 · Cited by 534
The relationship between blood groups and disease
Anstee, D. J. (2010) · Blood · doi:10.1182/blood-2010-01-261859 · Cited by 463
Genetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444
“cgi?l=2623">GATA1 -binding site, which inhibits DARC expression on erythrocyte”
BackgroundGao, J.-L., Wynn, T. A., Chang, Y., Lee, E. J., Broxmeyer, H. E., Cooper, S., Tiffany, H. L., Westphal, H., Kwon-Chung, J., & Murphy, P. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1959 · Cited by 441
When Less Is More: Gene Loss as an Engine of Evolutionary Change
Olson, M. V. (1999) · The American Journal of Human Genetics · doi:10.1086/302219 · Cited by 437
“One dramatic case involves the relationship between the Duffy-negative blood group and resistance to Plasmodium vivax (Tournamille et al. 1995), a malaria parasite that causes lesssevere disease than is caused by the better-known P. falciparum.”
BackgroundReich, D., Nalls, M. A., Kao, W. H. L., Akylbekova, E. L., Tandon, A., Patterson, N., Mullikin, J., Hsueh, W.-C., Cheng, C.-Y., Coresh, J., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000360 · Cited by 423
“The FY2 allele of rs2814778 has a 246 T to C substitution (non-coding strand) in the Duffy Antigen Receptor for Chemokines (DARC) gene, which disrupts a binding site for the GATA1 erythroid transcription factor [20].”
BackgroundImmune regulation by atypical chemokine receptors
Nibbs, R. J. B., & Graham, G. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3544 · Cited by 407
Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense
Barreiro, L. B., Ben-Ali, M., Quach, H., Laval, G., Patin, E., Pickrell, J. K., Bouchier, C., Tichit, M., Neyrolles, O., Gicquel, B., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000562 · Cited by 394
“For example, the excess of worldwide diversity at both HLA class I and II genes [34–37] and killer cell immunoglobulin-like receptors [38], as well as the high frequencies of the HbS allele [39–41] and the DARC null allele [42,43] in Africa, clearly attest for the action of natural selection on host genes in response…”
BackgroundThe Genetics of Transcription Factor DNA Binding Variation
Deplancke, B., Alpern, D., & Gardeux, V. (2016) · Cell · doi:10.1016/j.cell.2016.07.012 · Cited by 390
“HNF1A À58 bp HNF4A Loss (Gragnoli et al., 1997) Asthma IL10 À509 bp YY1 Gain (Hobbs et al., 1998) Pyruvate kinase deficiency PKLR À72 bp GATA1 Loss (Manco et al., 2000) Congenital erythropoietic porphyria UROS À70 bp; À90 bp GATA1; CP2 Loss (Solis et al., 2001) Psoriasis SLC9A3R1 À237 bp RUNX1 Loss (Helms et al., 2003…”
InfluentialPlasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people
Ménard, D., Barnadas, C., Bouchier, C., Henry-Halldin, C., Gray, L. R., Ratsimbasoa, A., Thonier, V., Carod, J.-F., Domarle, O., Colin, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912496107 · Cited by 383
“This sequencing showed identity between Duffy-negative Malagasy alleles and three West African FY*BES alleles and the FY*BES GenBank 5968 | www.pnas.org/cgi/doi/10.1073/pnas.0912496107 Ménard et al. reference sequence (X85785) (10) and verified that failure to detect the Duffy antigen by serology resulted from the −33…”
BackgroundInfluentialSelf-citationAbundant Raw Material for Cis-Regulatory Evolution in Humans
Rockman, M. V., & Wray, G. A. (2002) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a004023 · Cited by 376
“For example, a polymorphism at the FY locus affects expression in erythroid cells but not in other tissues (Tournamille et al. 1995).”
BackgroundCasanova, J.-L., Abel, L., & Quintana-Murci, L. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101335 · Cited by 366
Human-Specific Gain of Function in a Developmental Enhancer
Prabhakar, S., Visel, A., Akiyama, J. A., Shoukry, M., Lewis, K. D., Holt, A., Plajzer-Frick, I., Morrison, H., FitzPatrick, D. R., Afzal, V., et al. (2008) · Science · doi:10.1126/science.1159974 · Cited by 363
Weiss, M. J., Yu, C., & Orkin, S. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1642 · Cited by 354
“Potential erythroid target genes for GATA-1 include globins, erythroid transcription factors (including SCL/tal-1, erythroid Krüppel-like factor [EKLF] and GATA-1 itself), the Duffy antigen/chemokine receptor (45), and the erythropoietin (Epo) receptor (EpoR) (reference 52 and references therein).”
BackgroundDetection of the Signature of Natural Selection in Humans: Evidence from the Duffy Blood Group Locus
Hamblin, M. T., & Di Rienzo, A. (2000) · The American Journal of Human Genetics · doi:10.1086/302879 · Cited by 350
“Furthermore, the FY*O mutation has been identified as a single base change in a GATA1 regulatory element, resulting in the elimination of transcription of DARC mRNA in RBCs but not in other cell types (Tournamille et al. 1995).”
BackgroundLeukocidins: staphylococcal bi-component pore-forming toxins find their receptors
Spaan, A. N., van Strijp, J. A. G., & Torres, V. J. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.27 · Cited by 347
Chemokines in the CNS: plurifunctional mediators in diverse states
Asensio, V. C., & Campbell, I. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01453-8 · Cited by 345
Genome-wide scans for footprints of natural selection
Oleksyk, T. K., Smith, M. W., & O'Brien, S. J. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0219 · Cited by 340
“The resistance allele (FY*0) has been localized to a single nucleotide base substitution (T/C) of the ancestral allele (FY*B) at nucleotide 246 of the promoter region (Chaudhuri et al. 1995; Tournamille et al. 1995; Seixas et al. 2002).”
BackgroundPruenster, M., Mudde, L., Bombosi, P., Dimitrova, S., Zsak, M., Middleton, J., Richmond, A., Graham, G. J., Segerer, S., Nibbs, R. J. B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1675 · Cited by 339
“This is due to a single-nucleotide mutation in the promoter region of the gene encoding DARC that disrupts the binding site for erythroid transcription factor GATA-1 (ref”
BackgroundSystematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits
Ulirsch, J. C., Nandakumar, S. K., Wang, L., Giani, F. C., Zhang, X., Rogov, P., Melnikov, A., McDonel, P., Do, R., Mikkelsen, T. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.048 · Cited by 328
From Malaria to Chemokine Receptor: The Emerging Physiologic Role of the Duffy Blood Group Antigen
Hadley, T. J., & Peiper, S. C. (1997) · Blood · doi:10.1182/blood.v89.9.3077 · Cited by 296
Moon, R. W., Hall, J., Rangkuti, F., Ho, Y. S., Almond, N., Mitchell, G. H., Pain, A., Holder, A. A., & Blackman, M. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216457110 · Cited by 283
“Three major Duffy alleles exist: Fy and Fy, which differ by a Gly42Asp substitution, and Fy, in which a point mutation in the promoter region abolishes Duffy expression in RBC (19).”
BackgroundChemokines and Chemokine Receptors: Biology and Clinical Relevance in Inflammation and AIDS
Locati, M., & Murphy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.425 · Cited by 283
Complex Signatures of Natural Selection at the Duffy Blood Group Locus
Hamblin, M. T., Thompson, E. E., & Di Rienzo, A. (2002) · The American Journal of Human Genetics · doi:10.1086/338628 · Cited by 278
Kowalski, M. H., Qian, H., Hou, Z., Rosen, J. D., Tapia, A. L., Shan, Y., Jain, D., Argos, M., Arnett, D. K., Avery, C., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008500 · Cited by 277
“Inverse-variance weighted meta-analysis were further carried out using GWAMA(60), separately for AAs and Hispanics/Latinos.”
BackgroundInfluentialThe human model: a genetic dissection of immunity to infection in natural conditions
Casanova, J.-L., & Abel, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1264 · Cited by 277
“The single-nucleotide mutation in the promoter of the DARC gene that is responsible for this resistance is recessive and specifically prevents transcription of the gene by cells of the erythroid lineag”
BackgroundAspects of Genetic Susceptibility to Human Infectious Diseases
Hill, A. V. S. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090546 · Cited by 266
“F or p er so na l u se o nl y. Table 1 Some replicated genetic associations with human infectious diseases∗ Disease Genetic locus Malaria alpha-globin, beta-globin, G6PD, SLC4A1, MAL/TIRAP, DARC Tuberculosis HLA-DR, INF-γ, SLC11A1, VDR, MAL/TIRAP, CCL2 HIV/AIDS HLA-B, CCR5, CCR2, RANTES Bacteremia∗∗ MBL2, PTPN22, CD32…”
BackgroundThe Genomics and Genetics of Human Infectious Disease Susceptibility
Hill, A. V. S. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.373 · Cited by 264
Unwelcomed Guests with Master Keys: How HIV Uses Chemokine Receptors for Cellular Entry
Doms, R. W., & Peiper, S. C. (1997) · Virology · doi:10.1006/viro.1997.8703 · Cited by 251
Karamatic Crew, V., Burton, N., Kagan, A., Green, C. A., Levene, C., Flinter, F., Brady, R. L., Daniels, G., & Anstee, D. J. (2004) · Blood · doi:10.1182/blood-2004-04-1512 · Cited by 249
Regulatory polymorphisms underlying complex disease traits.
Knight, J. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0603-7 · Cited by 246
“A number of examples involving SNPs are discussed below, including the role of polymorphism of CTLA4, encoding cytotoxic T lymphocyte antigen 4, in determining susceptibility to autoimmune disease [30] and polymorphism of DARC, encoding Duffy antigen receptor for chemokines, in malaria [31].”
BackgroundDesbaillets, I., Diserens, A.-C., Tribolet, N. D., Hamou, M.-F., & Meir, E. G. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1201 · Cited by 243
“It is noteworthy that this vascular staining is not the result of vessel cell or extracellular matrix binding of DARC released from erythrocytes, since this staining was maintained in individuals lacking erythroid DARC gene expression, due to a mutation disrupting a binding site for the GATA1 erythroid transcription f…”
BackgroundThe study of eQTL variations by RNA-seq: from SNPs to phenotypes
Majewski, J., & Pastinen, T. (2011) · Trends in Genetics · doi:10.1016/j.tig.2010.10.006 · Cited by 232
Emergence of FY*A null in a Plasmodium vivax -endemic region of Papua New Guinea
Zimmerman, P. A., Woolley, I., Masinde, G. L., Miller, S. M., McNamara, D. T., Hazlett, F., Mgone, C. S., Alpers, M. P., Genton, B., Boatin, B. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13973 · Cited by 231
RYAN, J. R., STOUTE, J. A., AMON, J., DUNTON, R. F., MTALIB, R., KOROS, J., OWOUR, B., LUCKHART, S., WIRTZ, R. A., BARNWELL, J. W., et al. (2006) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.575 · Cited by 230
Severe infectious diseases of childhood as monogenic inborn errors of immunity
Casanova, J.-L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521651112 · Cited by 228
“An elegant set of follow-up studies demonstrated that this resistance could be attributed to a single nucleotide mutation in the DARC promoter, preventing the binding of the transcription factor GATA-binding protein 1 (GATA1), which is required for DARC expression in the erythrocyte lineage (4).”
BackgroundAfrican origin of the malaria parasite Plasmodium vivax
Liu, W., Li, Y., Shaw, K. S., Learn, G. H., Plenderleith, L. J., Malenke, J. A., Sundararaman, S. A., Ramirez, M. A., Crystal, P. A., Smith, A. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms4346 · Cited by 227
Rapid Evolution of cis-Regulatory Sequences via Local Point Mutations
Stone, J. R., & Wray, G. A. (2001) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a003964 · Cited by 224
Schecter, A. D., Rollins, B. J., Zhang, Y. J., Charo, I. F., Fallon, J. T., Rossikhina, M., Giesen, P. L. A., Nemerson, Y., & Taubman, M. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28568 · Cited by 223
Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC)
Dawson, T. C., Lentsch, A. B., Wang, Z., Cowhig, J. E., Rot, A., Maeda, N., & Peiper, S. C. (2000) · Blood · doi:10.1182/blood.v96.5.1681 · Cited by 217
Admixture Mapping Comes of Age
Winkler, C. A., Nelson, G. W., & Smith, M. W. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141523 · Cited by 215
The Genetic Architecture of Adaptations to High Altitude in Ethiopia
Alkorta-Aranburu, G., Beall, C. M., Witonsky, D. B., Gebremedhin, A., Pritchard, J. K., & Di Rienzo, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003110 · Cited by 209
“Moreover, the null allele (FY*0) at the Duffy blood group locus, which protects against Plasmodium vivax malaria [37] and predicts white blood cell and neutrophil counts [38], has the second highest value.”
BackgroundHupalo, D. N., Luo, Z., Melnikov, A., Sutton, P. L., Rogov, P., Escalante, A., Vallejo, A. F., Herrera, S., Arévalo-Herrera, M., Fan, Q., et al. (2016) · Nature Genetics · doi:10.1038/ng.3588 · Cited by 209
Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity
Seilie, E. S., & Bubeck Wardenburg, J. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.04.003 · Cited by 207
Skelly, D. A., Johansson, M., Madeoy, J., Wakefield, J., & Akey, J. M. (2011) · Genome Research · doi:10.1101/gr.119784.110 · Cited by 203
Weatherall, D. J., Miller, L. H., Baruch, D. I., Marsh, K., Doumbo, O. K., Casals-Pascual, C., & Roberts, D. J. (2002) · Hematology · doi:10.1182/asheducation-2002.1.35 · Cited by 193
Zhang, Z. D., Frankish, A., Hunt, T., Harrow, J., & Gerstein, M. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r26 · Cited by 196
“unitary pseudogenes with fixed disruptive nucleotide substitutions, human genes with polymorphic disruptive sites that are currently segregating in the human population have also been indentified [8-10], and many of them provide the genetic bases of certain inheritable diseases [11].”
BackgroundLoss-of-function variants in the genomes of healthy humans
MacArthur, D. G., & Tyler-Smith, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq365 · Cited by 196
“The DARC coding region is intact and the protein is expressed in other tissues, but an SNP 46 bp upstream of the transcription start site disrupts a binding site for the erythroid transcription factor GATA1 and abolishes red cell expression (31).”
BackgroundMcDermott, D. H., Beecroft, M. J., Kleeberger, C. A., Al-Sharif, F. M., Ollier, W. E. R., Zimmerman, P. A., Boatin, B. A., Leitman, S. F., Detels, R., Hajeer, A. H., et al. (2000) · AIDS · doi:10.1097/00002030-200012010-00006 · Cited by 197
He, W., Neil, S., Kulkarni, H., Wright, E., Agan, B. K., Marconi, V. C., Dolan, M. J., Weiss, R. A., & Ahuja, S. K. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.002 · Cited by 194
“The 46C allele disrupts the binding site for the erythroid-specific transcription factor GATA-1, and consequently, the 46C/C DARC promoter genotype results in selective loss of expression of DARC on RBCs but not other cell types on which DARC is expressed (Tournamille et al., 1995).”
BackgroundMethodInfluentialMendes, C., Dias, F., Figueiredo, J., Mora, V. G., Cano, J., de Sousa, B., do Rosário, V. E., Benito, A., Berzosa, P., & Arez, A. P. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001192 · Cited by 190
“invasion. DARC-coding gene is polymorphic with multiple alleles as the codominant FY*A and FY*B, which encode for the two antigens – Fya and Fyb. Four genotypes are possible as a result of the combination of the major alleles, Fy(a+b+), Fy(a+b−), Fy(a−b+) and Fy(a−b−)”
BackgroundMalaria Genomic Epidemiology Network, Band, G., Le, Q. S., Clarke, G. M., Kivinen, K., Hubbart, C., Jeffreys, A. E., Rowlands, K., Leffler, E. M., Jallow, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13480-z · Cited by 189
Red blood cell blood group antigens: structure and function
Reid, M. E., & Mohandas, N. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.01.001 · Cited by 187
Inborn errors of immunity to infection
Casanova, J.-L., & Abel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050854 · Cited by 187
“It is clear that individuals homozygous for the wild-type DARC , CCR5 , and FUT2 alleles are intrinsically immunodeficient with regard to particular pathogens, whereas mutant individuals display greater immunity to these pathogens, with no apparent fitness cost.”
BackgroundInfluentialHuman genetics of infectious diseases: between proof of principle and paradigm
Alcaïs, A., Abel, L., & Casanova, J.-L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38111 · Cited by 182
Life‐threatening infectious diseases of childhood: single‐gene inborn errors of immunity?
Alcaïs, A., Quintana‐Murci, L., Thaler, D. S., Schurr, E., Abel, L., & Casanova, J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05834.x · Cited by 181
Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases
Quintana-Murci, L., Alcaïs, A., Abel, L., & Casanova, J.-L. (2007) · Nature Immunology · doi:10.1038/ni1535 · Cited by 181
Abel, L., Fellay, J., Haas, D. W., Schurr, E., Srikrishna, G., Urbanowski, M., Chaturvedi, N., Srinivasan, S., Johnson, D. H., & Bishai, W. R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30623-0 · Cited by 171
Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA
Mummidi, S., Bamshad, M., Ahuja, S. S., Gonzalez, E., Feuillet, P. M., Begum, K., Galvis, M. C., Kostecki, V., Valente, A. J., Murthy, K. K., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000169200 · Cited by 169
Chemokines and allergic disease
Nickel, R., Beck, L. A., Stellato, C., & Schleimer, R. P. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70281-2 · Cited by 163
The biochemistry and biology of the atypical chemokine receptors
Graham, G. J., Locati, M., Mantovani, A., Rot, A., & Thelen, M. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.004 · Cited by 163
Enhancer grammar in development, evolution, and disease: dependencies and interplay
Jindal, G. A., & Farley, E. K. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.016 · Cited by 154
“For example, in an enhancer for the membrane protein Duffy, a point mutation results in malarial resistance (Tournamille et al., 1995).”
BackgroundLi, B., & Ritchie, M. D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.713230 · Cited by 181
Möller, M., Jöud, M., Storry, J. R., & Olsson, M. L. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016001867 · Cited by 162
Invasion of host cells by malaria parasites: a tale of two protein families
Iyer, J. K., Grüner, A. C., Rénia, L., Snounou, G., & Preiser, P. R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05791.x · Cited by 147
“It is now known that the Duffy determinant is actually a chemokine receptor (DARC) whose expression is prevented in erythroid but not in nonerythroid cells as a result of mutation of the promoter at the GATA box (Tournamille et al., 1995).”
BackgroundCasanova, J., & Abel, L. (2022) · Cell · doi:10.1016/j.cell.2022.07.004 · Cited by 165
“Defects of the membrane attack complex of complement (underlying virus) were described later, from different angles, as XLP, like EV, was described a whereas complement defects were found serendipitously in sporadic cases of Ne infectious agents was first detected in the 1970s, with the Duffy antigen recepto basis of…”
Wang, J., Ou, Z.-L., Hou, Y.-F., Luo, J.-M., Shen, Z.-Z., Ding, J., & Shao, Z.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209703 · Cited by 147
“The Duffy-negative blood phenotype comes from a single T to C promoter mutation (Tournamille et al., 1995; Castilho et al., 2004; Chaudhuri et al., 2004).”
BackgroundUlvmar, M. H., Hub, E., & Rot, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.012 · Cited by 156
“This polymorphic change terminates transcription of DARC in erythroid cells only [24] and represents the third major allele, the erythroid silent FY*B(ES).”
BackgroundInfluentialHuman genetics of infectious diseases: a unified theory
Casanova, J., & Abel, L. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601558 · Cited by 168
“The spread of the deleterious haemoglobin S (Allison, 1954; Lederberg, 1999; Allison, 2002) and DARC (Miller et al, 1975, 1976; Tournamille et al, 1995) alleles within human populations in regions endemic for P. falcipar- um and Plasmodium vivax, respectively, indicated that microbe-driven natural…”
Red cell genotyping and the future of pretransfusion testing
Anstee, D. J. (2009) · Blood · doi:10.1182/blood-2008-11-146860 · Cited by 152
The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth
Shen, H., Schuster, R., Stringer, K. F., Waltz, S. E., & Lentsch, A. B. (2006) · The FASEB Journal · doi:10.1096/fj.05-4764com · Cited by 139
“We propose that the greater mortality to prostate cancer in men of African descent is due in part to the genetic mutation that prevents expression of the DARC on erythrocytes that evolved long ago as a natural selection against malaria infection ( 15 ).”
BackgroundTournamille, C., Le Van Kim, C., Gane, P., Le Pennec, P. Y., Roubinet, F., Babinet, J., Cartron, J. P., & Colin, Y. (1998) · Blood · doi:10.1182/blood.v92.6.2147 · Cited by 137
Self-citationRowe, J. A., Opi, D. H., & Williams, T. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283313de0 · Cited by 152
“The Fy(a−b−) Duffy negative phenotype resulting from a GATA-1 mutation in the promoter region of the DARC gene [9] has reached fixation in much of west and central Africa and accounts for the absence of P. vivax malaria from the region [3].”
Dual host–virus arms races shape an essential housekeeping protein
Demogines, A., Abraham, J., Choe, H., Farzan, M., & Sawyer, S. L. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001571 · Cited by 133
“A cis-regulatory polymorphism that silences DARC expression in erythrocytes has arisen independently in human populations from different parts of the world and is highly protective against Plasmodium vivax and Plasmodium knowlesi infection [24,25].”
D6 and the atypical chemokine receptor family: Novel regulators of immune and inflammatory processes
Graham, G. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200838858 · Cited by 133
Chaudhuri, A., Nielsen, S., Elkjaer, M.-L., Zbrzezna, V., Fang, F., & Pogo, A. O. (1997) · Blood · doi:10.1182/blood.v89.2.701 · Cited by 133
“Antisera, anti-Fy a and anti-Fy , substitution is present in the promoter region of Duffy-negadefine four phenotypes: Fy(a/b0), Fy(a0b/), Fy(a/b/), tive individuals.(20) This mutation affects the promoter activity and Fy(a0b0).”
BackgroundComparative Genomics Search for Losses of Long-Established Genes on the Human Lineage
Zhu, J., Sanborn, J. Z., Diekhans, M., Lowe, C. B., Pringle, T. H., & Haussler, D. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030247 · Cited by 129
“The bestknown examples are losses of cell surface receptors to confer pathogenic resistance, such as the inactivation of the DUFFY gene contributing to malaria resistance [1] and homozygosity for a null allele of chemokine receptor CCR5 conveying resistance to infection by various pathogens, including HIV [2].”
BackgroundDNA from blood samples can be used to genotype patients who have recently received a transfusion
Reid, M. E., Rios, M., Powell, V. I., Charles‐Pierre, D., & Malavade, V. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40010048.x · Cited by 127
The molecular genetics of blood group polymorphism
Daniels, G. L. (2005) · Transplant Immunology · doi:10.1016/j.trim.2005.03.003 · Cited by 152
Molecular biology and genetics of the Rh blood group system
Huang, C., Liu, P. Z., & Cheng, J. G. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90040-4 · Cited by 139
Contribution of Duffy antigen to chemokine function
Rot, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.011 · Cited by 126
Schöneberg, T., & Liebscher, I. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000011 · Cited by 120
“Lack of Duffy antigen expression or inactivating mutations in Duffy confer some degree of resistance against amalaria form (Plasmodium vivax) (Tournamille et al., 1995; Tamasauskas et al., 2001).”
BackgroundCnidarians and ancestral genetic complexity in the animal kingdom
Miller, D. J., Ball, E. E., & Technau, U. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.002 · Cited by 134
Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis
Duchêne, J., Novitzky‐Basso, I., Thiriot, A., Casanova-Acebes, M., Bianchini, M., Etheridge, S. L., Hub, E., Nitz, K., Artinger, K., Eller, K., et al. (2017) · Nature Immunology · doi:10.1038/ni.3763 · Cited by 134
Wallace, T. A., Martin, D., & Ambs, S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr066 · Cited by 126
Human Mannose-binding Lectin in Immunity
Casanova, J., & Abel, L. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040537 · Cited by 135
“For example, a regulatory mutation in the gene encoding the Duffy antigen chemokine receptor confers resistance to Plasmodium vivax and accounts for the expansion of the mutant allele in endemic areas (35).”
BackgroundThe duffy protein: A malarial and chemokine receptor
Pogo, A. O., & Chaudhuri, A. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90037-4 · Cited by 120
Pirenne, F., Tournamille, C., Bierling, P., Roudot‐Thoraval, F., Pennec, P. L., Rouger, P., & Ansart‐Pirenne, H. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00900.x · Cited by 118
Self-citation
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.